Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-12-23
1999-10-19
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 424 934, 4242781, 530350, A61K 3904, A61K 3900, A61K 4500, A01N 6300
Patent
active
059685247
ABSTRACT:
Methods for the treatment of skin disorders, including psoriasis, atopic dermatitis, allergic contact dermatitis, alopecia areata and skin cancers are provided, such methods comprising administering multiple doses of a composition having antigenic and/or adjuvant properties. Compositions which may be usefully employed in the inventive methods include inactivated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells, M. vaccae culture filtrate and compounds present in or derived therefrom, together with combinations of such compositions.
REFERENCES:
patent: 3956481 (1976-05-01), Jolles et al.
patent: 4036953 (1977-07-01), Adam et al.
patent: 4716038 (1987-12-01), Stanford et al.
patent: 4724144 (1988-02-01), Rook et al.
patent: 4877612 (1989-10-01), Berger et al.
patent: 5599545 (1997-02-01), Stanford et al.
patent: 5833996 (1998-11-01), Sanford et al.
R.G. White et al., "Correlation of Adjuvant Activity and Chemical Structure of Wax D Fractions of Mycobacteria," Immunology 7, pp. 158-171, 1964.
R.G. White, "Characterization of Micobacterial Components of Adjuvant Mixtures," Symposium Series Immunobiol. Standard 6, pp. 49-58, 1967.
R.G. White et al., The Influence of Components of M. Tuberculosis and other Mycobacteria upon Antibody Production to Ovalbumin, Immunology I, pp. 54-66, 1958.
Lehrer, A. et al. Immunotherapy with Mycobaterium vaccae in the treatment of psoriasis, FEMS Immunology and Medical Microbiology 21:71-77, 1998.
C Abou-Zeid et al. Infect. Immun. 65 (May): 1856-1862, 1997.
WH Burgess et al. J. Cell Biol. 111: 2129-2138, 1990.
E Lazar et al. Mol. Cellular Biol. 8: 1247-1252, 1988.
Khandeker et al. Int. J. Lepr. Other Mycobact. Dis. 54(3): 416-422, 1986.
Navalkar et al. Int. J. Lepr. Other Mycobact. Dis. 48(4): 388-396, 1980.
Hiu, Nature 267: 708-709, 1977.
Hiu, Jpn. J. Exp. Med. 50(3): 183-188, 1980.
Thompson et al. Autoimmunity 11(1): 35-43, 1991.
Meyer et al. Immunology 28(2): 219-229 (Abstract) 1975.
Kobatake et al. Agric. Biol. Chem. 51(3): 691-697 (Abstract) 1987.
Skinner et al. Vaccine Weekly, Oct. 1997, p. 23, 1997.
Skinner et al. Infect. Immun. 65(11): 4525-4530, Nov., 1997.
Markeletter, Apr. 22, p. 21, 1991.
Bay et al. FEMS Immunol. Med. Microbiol. 21: 65-70, 1998.
Ramu et al. Indian Med. Gazette 124: 381-382, 1990.
Tan Paul L. J.
Watson James D.
Devi S.
Genesis Research & Development Corp.
Housel James C.
Sleath Janet
Speckman Ann W.
LandOfFree
Methods and compounds for the treatment of immunologically-media does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compounds for the treatment of immunologically-media, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compounds for the treatment of immunologically-media will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052240